2.0
2 Jul 2020
Former employee, more than 10 years
South San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
Father of BioOncology. Created targeted oncology and hematology products that changed the course of the disease.
Cons
Will never be DNA again. Massive layoffs of long term highly skilled employees over the past six years (60+%). The departure of early and late-stage researchers has impacted future opportunities. They "don't need people managers." Little to no support from HR for retaliation and bad managers. No exit interviews. No action is taken to protect employees—multiple civil suits.